We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
-27.19%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$7.34B
AUM Growth
-$3.86B
Cap. Flow
-$375M
Cap. Flow %
-5.12%
Top 10 Hldgs %
9.89%
Holding
1,223
New
86
Increased
388
Reduced
436
Closed
75

Top Buys

Rank Stock Value
1
ESE icon
ESCO Technologies
ESE
+$40.8M
2
HAE icon
Haemonetics
HAE
+$37.6M
3
ROG icon
Rogers Corp
ROG
+$26.2M
4
EVR icon
Evercore
EVR
+$25.5M
5
FARO
Faro Technologies
FARO
+$22M

Sector Composition

Rank Sector Weight
1 Industrials 25.72%
2 Technology 19.64%
3 Financials 14.17%
4 Consumer Discretionary 10.37%
5 Healthcare 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATEC icon
501
Alphatec Holdings
ATEC
$1.56B
$3.03M 0.04%
878,836
+10,000
+1% +$57.5K
MG icon
502
Mistras Group
MG
$495M
$3.02M 0.04%
708,850
+80,591
+13% +$736K
PCSB
503
DELISTED
PCSB Financial Corporation
PCSB
$3.02M 0.04%
215,600
-12,100
-5% -$218K
GWW icon
504
W.W. Grainger
GWW
$64.8B
$3.01M 0.04%
12,100
+10,100
+505% +$2.99M
UFS
505
DELISTED
DOMTAR CORPORATION (New)
UFS
$2.99M 0.04%
138,219
-2,175
-2% -$69.3K
CMI icon
506
Cummins
CMI
$89.5B
$2.98M 0.04%
22,000
LFCR icon
507
Lifecore Biomedical
LFCR
$166M
$2.95M 0.04%
339,028
+263,418
+348% +$2.74M
LXP icon
508
LXP Industrial Trust
LXP
$3.57B
$2.92M 0.04%
58,897
EVH icon
509
Evolent Health
EVH
$359M
$2.9M 0.04%
533,411
+62,000
+13% +$554K
ABG icon
510
Asbury Automotive
ABG
$4.26B
$2.89M 0.04%
52,343
+2,600
+5% +$226K
NVEE
511
DELISTED
NV5 Global
NVEE
$2.85M 0.04%
+275,600
New +$3.68M
ITW icon
512
Illinois Tool Works
ITW
$82.8B
$2.84M 0.04%
20,000
+1,300
+7% +$221K
GFN
513
DELISTED
General Finance Corporation
GFN
$2.84M 0.04%
455,382
+81,642
+22% +$732K
FRST icon
514
Primis Financial Corp
FRST
$405M
$2.82M 0.04%
286,498
-39,300
-12% -$550K
PROF
515
Profound Medical
PROF
$303M
$2.82M 0.04%
293,000
+98,000
+50% +$1.27M
ICBK
516
DELISTED
County Bancorp, Inc. Common Stock
ICBK
$2.78M 0.04%
150,100
-5,500
-4% -$129K
PCYO icon
517
Pure Cycle
PCYO
$258M
$2.77M 0.04%
248,802
-91,692
-27% -$1.11M
ASYS icon
518
Amtech Systems
ASYS
$273M
$2.75M 0.04%
632,306
-33,535
-5% -$189K
PEN icon
519
Penumbra
PEN
$12.7B
$2.74M 0.04%
17,000
ADTN icon
520
Adtran
ADTN
$719M
$2.74M 0.04%
356,438
+80,000
+29% +$683K
MAG
521
DELISTED
MAG Silver
MAG
$2.71M 0.04%
352,950
UFPT icon
522
UFP Technologies
UFPT
$2.06B
$2.71M 0.04%
71,140
-1,583
-2% -$72.7K
ADUS icon
523
Addus HomeCare
ADUS
$2.19B
$2.7M 0.04%
40,000
+2,488
+7% +$215K
LEGH icon
524
Legacy Housing
LEGH
$631M
$2.67M 0.04%
289,025
RNGR icon
525
Ranger Energy Services
RNGR
$377M
$2.67M 0.04%
658,228
-48,661
-7% -$299K

Similar funds

Royce & Associates's Q1 2020 Portfolio in Review

As of Q1 2020, Royce & Associates held 1,223 positions worth $7.34B, down 34% from $11.2B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Royce & Associates withdrew a net $375M in Q1 2020, closing 75 positions and reducing 436 holdings. Its most notable exit was AVX Corporation, an estimated $71.1M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

Against the trend, Royce & Associates opened a new position in ESCO Technologies worth $33.9M.

  • Royce & Associates's largest Q1 2020 buy was ESCO Technologies: 447,118 shares worth $33.9M.
  • Royce & Associates added most to Haemonetics in Q1 2020, an estimated $37.6M increase.
  • Royce & Associates's biggest Q1 2020 reduction was Virtu Financial, cutting an estimated $51M.
  • Royce & Associates fully exited AVX Corporation in Q1 2020, selling an estimated $71.1M.
  • Royce & Associates's ten largest holdings make up 9.9% of its $7.34B portfolio in Q1 2020.
  • Royce & Associates opened 86 new positions and closed 75 in Q1 2020.
  • Royce & Associates's portfolio value fell 34% quarter-over-quarter to $7.34B.

Based on Royce & Associates's 13F filing for Q1 2020, filed 12 May 2020.